First Time Loading...

Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 37.24 USD 10.24% Market Closed
Updated: May 15, 2024

Balance Sheet

Balance Sheet Decomposition
Biohaven Pharmaceutical Holding Company Ltd

Current Assets 442.4m
Cash & Short-Term Investments 381.8m
Receivables 13.6m
Other Current Assets 47m
Non-Current Assets 70.8m
PP&E 48.6m
Intangibles 19.8m
Other Non-Current Assets 2.4m
Current Liabilities 55.4m
Accounts Payable 15.6m
Accrued Liabilities 39.8m
Non-Current Liabilities 29.8m
Other Non-Current Liabilities 29.8m

Balance Sheet
Biohaven Pharmaceutical Holding Company Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
83
76
205
248
Cash
83
76
205
248
Short-Term Investments
0
0
261
133
Total Receivables
0
0
46
14
Other Current Assets
7
19
75
47
Total Current Assets
90
95
587
442
PP&E Net
8
13
52
49
PP&E Gross
8
13
52
49
Accumulated Depreciation
2
3
5
8
Intangible Assets
0
18
18
18
Goodwill
0
1
1
1
Long-Term Investments
1
0
0
0
Other Long-Term Assets
13
14
3
2
Other Assets
0
1
1
1
Total Assets
112
N/A
142
+27%
662
+366%
513
-22%
Liabilities
Accounts Payable
3
5
11
16
Accrued Liabilities
27
37
44
40
Short-Term Debt
0
0
0
0
Other Current Liabilities
0
0
35
0
Total Current Liabilities
30
42
90
55
Long-Term Debt
0
0
0
0
Minority Interest
60
60
0
0
Other Liabilities
5
5
33
30
Total Liabilities
95
N/A
107
+13%
123
+15%
85
-31%
Equity
Common Stock
0
0
616
888
Retained Earnings
0
0
91
499
Additional Paid In Capital
0
0
14
40
Other Equity
17
35
0
0
Total Equity
17
N/A
35
+107%
539
+1 453%
428
-21%
Total Liabilities & Equity
112
N/A
142
+27%
662
+366%
513
-22%
Shares Outstanding
Common Shares Outstanding
64
64
68
81

See Also

Discover More